The study's authors urged physicians to use caution when prescribing these medications for "off-label indications." 

Willerson's research spanned decades and included topics such as unstable atherosclerotic plaques and human stem cells. He is remembered for his passion and the impact he made on those around him. 

The study's authors identified dozens of potential new biomarkers, sharing their findings in the Proceedings of the National Academy of Sciences.

The map, part of a study published in Nature, can provide new details about cellular structure and how cells interact with one another. It could even help with the treatment of COVID-19. 

The study focused on more than 1,400 TAVR patients treated from August 2007 to June 2018. 

Gary Idelchik, MD, has filed a lawsuit against BayCare Health System in Florida.

One key detail is that no stent thrombosis events were reported among the study's 201 participants. 

It also takes longer for stroke patients to fully recover when they have COVID-19.

The study tracked nearly 500 patients for more than two decades. 

Recurrent coronary heart disease is also on the decline, according to a new analysis published in Circulation.

Cardiac MR imaging has shown potential to detect signs of myocarditis in recovered COVID-19 patients.